{"version":"1.0","provider_name":"EVER Pharma","provider_url":"https:\/\/www.everpharma.com\/de\/","author_name":"Magdalena","author_url":"https:\/\/www.everpharma.com\/de\/author\/mschmitzberger\/","title":"EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate - EVER Pharma","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"I0tgKFEU8N\"><a href=\"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/\">EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.everpharma.com\/de\/news\/ever-pharma-erhaelt-eu-zulassung-fuer-testosteronenantate\/embed\/#?secret=I0tgKFEU8N\" width=\"600\" height=\"338\" title=\"&#8222;EVER Pharma erh\u00e4lt EU-Zulassung f\u00fcr Testosteronenantate&#8220; &#8211; EVER Pharma\" data-secret=\"I0tgKFEU8N\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.everpharma.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"EVER Pharma, ein vollintegrierter Pharmaspezialist, hat die Zulassung von Testosteronenantate in der Europ\u00e4ischen Union f\u00fcr die Behandlung des m\u00e4nnlichen Hypogonadismus bekannt gegeben. Diese Erkrankung, die durch unzureichende Testosteronproduktion gekennzeichnet ist, betrifft weltweit bis zu 10% der M\u00e4nner und 40% der M\u00e4nner im Alter von 45 Jahren1. M\u00e4nnlicher Hypogonadismus kann die Lebensqualit\u00e4t erheblich beeintr\u00e4chtigen und sich &hellip; Weiterlesen","thumbnail_url":"https:\/\/www.everpharma.com\/wp-content\/uploads\/2024\/08\/TEN-PR-Image-1024x1024.png"}